|
|
Article: SR PHARMA PLC - Acquisition(s).
- Article from:
- PR Newswire UK Disclose
- Article date:
- June 21, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SR PHARMA TO ACQUIRE ATUGEN
Proposed acquisition and temporary suspension
21 June 2005 - London - SR Pharma plc ("SR Pharma" or "the Company") is pleased
to announce that it has entered into a conditional agreement to acquire Atugen
AG ("Atugen"), a biotechnology company based in Berlin, Germany.
By virtue of its size, the transaction constitutes a reverse take-over under
the AIM Rules and as such requires the approval of SR Pharma shareholders. The
Company expects to post a circular to shareholders later this week containing
full details of the transaction and convening an extraordinary general meeting
of the Company to approve the acquisition. The Company has ...
Related newspaper, magazine, and journal articles:
|
|
Article: Atugen Appoints Klaus Giese to Vice President of Research.
PR Newswire;
January 11, 1999 ;
692 words
...BERLIN, Jan. 11 /PRNewswire/ -- Atugen Biotechnology GmbH ("Atugen") today announced the appointment of Klaus Giese ... to the position of Vice President of Research at Atugen. He will relocate to Atugen in Berlin from his current ...
|
|